Evidence map›Paper›PMID 21874350›Full record

ReviewCellular and molecular life sciences : CMLS2011

Insights into NK cell biology from human genetics and disease associations.

Stephanie M Wood, Hans-Gustaf Ljunggren, Yenan T Bryceson

Abstract readReview
In one paragraph

Review in Cellular and molecular life sciences : CMLS, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Candidiasis in breast cancer: Tumor progression or not?Iranian journal of basic medical sciences · 2024
    Review
  2. Review
  3. Article
  4. Observational
  5. Review
  6. Article
  7. Article
  8. NK Cells in HIV Disease.Current HIV/AIDS reports · 2016
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Natural killer cell deficiency.The Journal of allergy and clinical immunology · 2013
    Review
  16. Article
  17. Natural killer cells and antifungal host response.Clinical and vaccine immunology : CVI · 2013
    Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Stephanie M WoodDepartment of Medicine, Center for Infectious Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, 14186 Stockholm, Sweden. stephanie.wood@ki.se
Hans-Gustaf Ljunggren
Yenan T Bryceson

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rare human primary immunodeficiency disorders with extreme susceptibility to infections in infancy have provided important insights into immune function. Increasingly, however, primary immunodeficiencies are also recognized as a cause of other more common, often discrete, infectious susceptibilities. In a wider context, loss-of-function mutations in immune genes may also cause disorders of immune regulation and predispose to cancer. Here, we review the associations between human diseases and mutations in genetic elements affecting natural killer (NK) cell development and function. Although many such genetic aberrations significantly reduce NK cell numbers or severely impair NK cell responses, inferences regarding the role of NK cells in disease are confounded by the fact that most mutations also affect the development or function of other cell types. Still, data suggest an important role for NK cells in diseases ranging from classical immunodeficiency syndromes with susceptibility to viruses and other intracellular pathogens to cancer, autoimmunity, and hypersensitivity reactions.

Indexed as

ExocytosisHumansImmunologic Deficiency SyndromesKiller Cells, NaturalLymphocyte ActivationReceptors, Natural Killer CellT-Lymphocytes, CytotoxicReceptors, Natural Killer Cell

Identifiers

PMID21874350
PMCPMC11115003

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.